Medicare Enrolled

Dr. Alan Manevitz, M.D.

Psychiatry · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
60 SUTTON PL S STE 1CN, New York, NY 10022
2127515072
Registered in NPPES since 2007
NPI: 1093860975 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Manevitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Manevitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Manevitz

Dr. Alan Manevitz is a psychiatry specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Manevitz performed 3,994 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Manevitz received a total of $7,667 from 22 pharmaceutical and/or device companies across 171 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Manevitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 1% volume in NY $7,667 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,994
Medicare services
Top 1% in NY for psychiatry
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
1,475 $72 $98
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
829 $163 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
778 $73 $107
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
766 $108 $147
Family psychotherapy, 50 minutes
A 50-minute therapy session involving the patient and their family members to address psychological or behavioral concerns.
81 $81 $120
Family psychotherapy without patient, 50 minutes
A 50-minute psychotherapy session conducted with family members in the absence of the patient.
25 $77 $105
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
24 $157 $325
Magnetic field treatment to stimulate brain nerve cells, initial delivery
A procedure that uses a magnetic field to stimulate nerve cells in the brain. This code covers the initial delivery and management of the treatment.
16 $283 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,667
Total received (2018-2024)
Avg $1,095/year across 7 years
Top 8% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
171
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$438
2023
$4,530
2022
$320
2021
$967
2020
$242
2019
$721
2018
$448

Payments by company (2024)

Alkermes, Inc.
$90
ABBVIE INC.
$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$80
Lundbeck LLC
$47
Janssen Pharmaceuticals, Inc
$34
Teva Pharmaceuticals USA, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$28
Otsuka America Pharmaceutical, Inc.
$25
Almatica Pharma LLC
$22
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Neuronetics, Inc.
$4,463
AbbVie Inc.
$523
ABBVIE INC.
$414
Takeda Pharmaceuticals U.S.A., Inc.
$402
Vanda Pharmaceuticals Inc.
$308
ITI, Inc.
$221
Allergan Inc.
$195
Allergan, Inc.
$159
Janssen Pharmaceuticals, Inc
$150
Bausch Health US, LLC
$141
Supernus Pharmaceuticals, Inc.
$120
Lundbeck LLC
$103
Otsuka America Pharmaceutical, Inc.
$93
Alkermes, Inc.
$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$80
Almatica Pharma LLC
$46
Sunovion Pharmaceuticals Inc.
$45
Teva Pharmaceuticals USA, Inc.
$32
Neurocrine Biosciences, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$24
LivaNova USA, Inc.
$17
Ironshore Pharmaceuticals Inc.
$11
Top 3 companies account for 70.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · APLENZIN · ARISTADA · Austedo XR · BRINTELLIX · CAPLYTA · Fanapt · HETLIOZ · Hetlioz · INGREZZA · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · QELBREE · REXULTI · SERTRALINE HCL · SPRAVATO · SUNOSI · TRINTELLIX · Trintellix · UBRELVY · VNS - Symmetry · VRAYLAR · VYVANSE · WELLBUTRIN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in New York?
Compare psychiatrists in the New York area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
5,026
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
NEW YORK-PRESBYTERIAN HOSPITAL
0.5 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Manevitz is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NY), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Manevitz experienced with 45-minute psychotherapy and evaluation visit?
Based on Medicare claims data, Dr. Manevitz performed 1,475 45-minute psychotherapy and evaluation visit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Manevitz receive payments from pharmaceutical companies?
Yes. Dr. Manevitz received a total of $7,667 from 22 companies across 171 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Manevitz's costs compare to other psychiatrists in New York?
Dr. Manevitz's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Manevitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →